BioCorRx (BICX) Return on Sales (2011 - 2026)

BioCorRx (BICX) posted Return on Sales of 0.04% for Q1 2026, down 131.21% sequentially from 0.02% in Q4 2025, and up 2.0% YoY from 0.04% in Q1 2025.

BioCorRx (BICX) Return on Sales (2011 - 2026) Analysis & Trends

BioCorRx has reported Return on Sales for 16 years, with the latest figure at 0.04% in Q1 2026.

Quarterly Return on Sales rose 2.0% year-over-year to 0.04% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.02% (up 33.0% YoY) and the FY2025 annual result came in at 0.04%, up 676.0% from the prior year.
Return on Sales eased to 0.04% in Q1 2026 per BICX's latest filing, from 0.02% in the prior quarter.
Over five years, Return on Sales peaked at 0.0% in Q3 2025 and troughed at 6.8% in Q4 2024.
A 5-year average of 1.11% and a median of 0.46% in 2022 frame the typical range for Return on Sales.
The sharpest annual moves came in 2024 and 2025: Return on Sales tumbled 629 bps in 2024, then surged 678 bps in 2025.
Over 5 years, Return on Sales stood at 0.14% in 2022, then plunged by 265 bps to 0.51% in 2023, then sank by 1229 bps to 6.8% in 2024, then surged by 100 bps to 0.02% in 2025, then plunged by 131 bps to 0.04% in 2026.
According to Business Quant data, Return on Sales over the past three periods registered 0.04%, 0.02%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROS (Qtr)
1	HCA Healthcare	88.19 Bn	90.61 Bn	15.19 Bn	0.00%
2	Tenet Healthcare	21.59 Bn	21.56 Bn	4.45 Bn	0.00%
3	Encompass Health	12.19 Bn	12.86 Bn	1.34 Bn	0.00%
4	Davita	11.52 Bn	12.39 Bn	1.16 Bn	0.00%
5	Ensign	10.59 Bn	10.27 Bn	306.24 Mn	0.00%
6	Universal Health Services	8.79 Bn	8.72 Bn	3.29 Bn	0.00%
7	Pacs	7.04 Bn	6.88 Bn	338.46 Mn	0.00%
8	Chemed	6.96 Bn	6.92 Bn	221.47 Mn	0.00%
9	Concentra Group Holdings Parent	4.52 Bn	4.38 Bn	192.10 Mn	0.00%
10	BioCorRx	1.49 Mn	1.47 Mn	-	-

Download Data